Behavioral strategy program X plus Y
BehavioralBrief 4 session education program with sleep specialist focused on behavioral strategies for improving use of sleep apnea therapy. Tests behavioral strategy program X plus Y.
NCT Number: NCT07207473
Previous studies have shown that programs encouraging the use of OSA treatments can help patients use these treatments more often, but the improvement is usually modest. This trial will test if giving patients a decision-making tool when they are first diagnosed with OSA, and combining their responses from this tool into a supportive program, will improve sleep quality and help them use their treatment more regularly.
Trial opening soon.
Get Notified50 year and older
All sexes
Interventional
Not applicable
VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles, California, United States
Background and Significance:
Obstructive Sleep Apnea (OSA) is a significant health issue for many middle-aged and older Veterans. This condition can lead to daytime sleepiness and poor sleep quality and is a risk factor for more serious conditions such as cardiovascular disease, cognitive decline, and even increased risk of death. Common treatments for OSA include the use of medical devices such as positive airway pressure machines or oral appliances. However, many Veterans find these devices uncomfortable or difficult to use regularly. This clinical trial aims to test a new 4 session program to help Veterans stick to their OSA treatment plans using a more person-centered approach.
Innovation and Impact:
This innovative, person-centered approach is integral to the VA's "age-friendly" healthcare transformation. By focusing on what matters most to older Veterans, the investigators aim to enhance their compliance with, and the effectiveness of, OSA therapy. Aligning OSA treatment decisions with each Veteran's health priorities is expected to improve their overall wellbeing and make OSA treatments more effective.
Specific Aims:
Methodology: The investigators will conduct a 5-year multi-site randomized controlled trial with a total of 128 Veterans across sites, aged 50 and older who have been newly diagnosed with OSA. Participants will be randomly assigned to either the new program or an active-control program (both programs include 1 self-directed session and 3 sessions delivered by sleep providers) that incorporate behavioral adherence strategies currently used in the investigators sleep centers. The research team will measure the outcomes 6 months after the program ends.
Path to Translation/Implementation:
The long-term goal of this work is to improve sleep quality and use of prescribed OSA therapies among middle-aged and older Veterans with OSA. If successful, the investigators will implement the intervention at the investigators' institutions and conduct a future type 2 hybrid design trial to test both the effectiveness of the program and its potential for wider implementation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Brief 4 session education program with sleep specialist focused on behavioral strategies for improving use of sleep apnea therapy. Tests behavioral strategy program X plus Y.
Brief 4 session education program with sleep specialist focused on behavioral strategies for improving use of sleep apnea therapy Tests behavioral strategy X.
Time frame: 6-months after the end of the intervention/control sessions, which is approximately 8 months after randomization.
The PSQI total score will be used as a measurement of sleep quality. Scores range from 0 to 21. Higher scores indicate worse outcome.
Time frame: One week after the end of the intervention/control sessions, which is approximately 2 months after randomization.
Percentage of participants prescribed device therapy with > 0 days of use in the 30 days prior to the 6-month follow-up timepoint.
Time frame: 6-months after the end of the intervention/control sessions, which is approximately 8 months after randomization.
Percentage of days of machine reported use >= 4 hours in the prior 30 days.
Time frame: End of session 1, which is within 7 days of randomization.
Decisional Conflict Scale "What's important" item. This item is scored as 0 (best) to 4 (worst).
Contact information is provided by the study sponsor or research team.
VA Office of Research and Development
Fed
Helping Veterans With Obstructive Sleep Apnea Determine What Matters Most in Choosing a Treatment Option: a Randomized Trial
Acronym: BOOST
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07465874
Apnea, Dyssomnias
Mardin, Turkey (Türkiye)
View Trial DetailsNCT07136272
Apnea, Dyssomnias
Burlingame, California, United States
View Trial DetailsNCT07095413
Apnea, Dyssomnias
View Trial DetailsNCT06818604
Apnea, Autonomic Dysreflexia
Vancouver, British Columbia, Canada
View Trial Details